FORMULATING FOR MILDNESS Retinyl palmitate (0.1%)
75.000 65.000 55.000 45.000 35.000 25.000 15.000 5.000 0
Retinol/retinal 10.000
95.000 85.000 75.000 65.000 55.000 45.000 35.000 25.000 15.000 5.000 0
Retinyl linoleate (0.1%) 95.000
Triplicate skin discs EpiDerm, 24h Etthylacetate extraction, LC/MS/MS
33
1 Figure 2: Chromatograms of retinyl esters and metabolites extracted from tissue treated as shown
in keratinocytes cultured from neonatal foreskin are notably high.6 While the expression of RA binding protein
CRABP2 was elevated in both the treated and control tissues, it is nonetheless noteworthy to see that the ligand-inducible retinoic acid receptor alpha (RARA) is up-regulated almost threefold by the R-LIN treatment. While the CRAPB2 protein binds RA, this complex is ultimately recognized by the receptor complex RARA upon its transfer to the nucleus.7 The differential regulation of this particular
retinoic acid receptor suggests that indeed the liberated retinol is being converted to RA in the cells and transported to the nucleus to participate in downstream gene regulation. Overall, up-regulation of specific retinoid
marker genes supports the role of R-LIN in a retinoid biochemical cascade when applied topically to cultured skin. Both the cellular retinol binding protein CRBP3 and the retinoic acid receptor alpha (RARA) are up-regulated by the R-LIN treatment, indicating that retinol is indeed being liberated from the retinyl ester by hydrolysis, bound by cellular binding proteins and subject to further enzymatic transformation to retinoic acid in the cultured cells.
Permeation and hydrolysis of retinyl esters in a skin model Results comparing the retinoids extracted from tissue treated with either retinyl palmitate or mixed retinyl esters are presented in the chromatograms in Figure 2. The retinyl esters used in the treatment are detected by the LC/ MS/MS analysis, indicating that they were able to permeate into the tissue of the skin model. In the panel on the left, the peaks
corresponding to retinyl palmitate are in dark green. In the panel on the right, the peaks corresponding to retinyl linoleate are blue-green, while the peaks corresponding to retinyl oleate are in pink. The analytical method does not distinguish retinyl linoleate from retinyl CLA. According to the LC/MS/MS results, the
www.personalcaremagazine.com stand number AC80 Please visit is on
2
3
4
5
6
7
8
9
April 2023 PERSONAL CARE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143